End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
99.72 EUR | -0.83% | -1.22% | -12.60% |
06-05 | Collective bargaining partners in the chemical industry adjourn again | DP |
05-31 | Wacker Chemie AG completed the acquisition of Assets of Bio Med Sciences Inc. | CI |
Sales 2024 * | 6.14B 6.64B 9.11B | Sales 2025 * | 6.6B 7.14B 9.8B | Capitalization | 4.88B 5.27B 7.23B |
---|---|---|---|---|---|
Net income 2024 * | 225M 243M 334M | Net income 2025 * | 413M 447M 613M | EV / Sales 2024 * | 0.84 x |
Net Debt 2024 * | 251M 272M 373M | Net Debt 2025 * | 197M 213M 292M | EV / Sales 2025 * | 0.77 x |
P/E ratio 2024 * |
22.3
x | P/E ratio 2025 * |
12.4
x | Employees | 16,425 |
Yield 2024 * |
2.47% | Yield 2025 * |
4.07% | Free-Float | 31.67% |
Latest transcript on Wacker Chemie AG
1 day | -0.83% | ||
1 week | -1.22% | ||
Current month | -2.00% | ||
1 month | -1.02% | ||
3 months | -3.93% | ||
6 months | -11.28% | ||
Current year | -12.60% |
Managers | Title | Age | Since |
---|---|---|---|
Christian Hartel
CEO | Chief Executive Officer | 53 | 15-10-31 |
Jörg Hoffmann
IRC | Investor Relations Contact | - | - |
Thomas Renner
PRN | Corporate Officer/Principal | - | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 73 | 08-05-07 | |
Matthias Biebl
BRD | Director/Board Member | 58 | 08-05-07 |
Susanne Weiss
BRD | Director/Board Member | 63 | 08-05-07 |
Date | Price | Change |
---|---|---|
24-06-12 | 99.44 | +1.16% |
24-06-11 | 98.3 | -1.42% |
24-06-10 | 99.72 | -0.83% |
24-06-07 | 100.6 | -0.15% |
24-06-06 | 100.7 | -0.30% |
End-of-day quote Wiener Boerse, June 09, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.64% | 19.56B | |
+4.10% | 4.13B | |
+17.20% | 1.56B | |
-4.54% | 1.19B | |
+18.59% | 977M | |
-16.94% | 639M | |
-37.78% | 544M | |
-22.29% | 260M | |
-5.64% | 248M |
- Stock Market
- Equities
- WCH Stock
- WCH Stock